3[2]Waagstein F,Bristow MR,Swedberg K,et al. Beneficial effect of metoprolol in idiopathic dilated cardiomyopathy [J ]. Lancet , 1993,342:1441
4[3]CIBIS Investigators and Committees. A randomized trial of B blockade it heart failure :the Cardlc Insufficiecy Bisoprolol Study(CIBIS)[J]. Circulation,1994,90:1765
5[4]Packer M ,Bristow RW,Cohn JN,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J]. N Engl J Med,1996,334:1349
6[5]Brlstow MR,Gilbert EM,Abraham WT,et al. Carvedilol produces dose-re lated improvements in left ventricular function and survival in subjects with chronic heart failure[J]. Circulation, 1996,94 (11 ): 2807
7[6]Bristow MR,Gilbert EM, Abraham WT,et al. Effect of c0arvedilol on LV function and mortality in diabetic versus nondiabetic patients with ischemlc of nonischemic dilated cardiomyopathy [J]. Circulation, 1996,94:(8)suppl.I:I-664
8[7]Australia-New Zealand Heart Failure Research Collaborative Group. Randomised,placebo-controlled trial of carvedilol in patient with congestive heart failure due to iscbemic heart disease[J]. Lancet,1997,349:375
9[8]Heidenreich PA, Lee TT,Massie BM. Effect of beta-blockade on mortality in patients with heart failure:a mata-analysis of randomized clinical trials [J]. J Am Coll Cardiol, 1997 , 30: 27
10[9]Bristow MR. Pathophysiologic and pharmacologic rational for clinical management of chronic heart failure with beta-blocking agents [J]. Am J Cardiol,1993,71:12C
